Quantitative Interstitial Abnormality Progression and Outcomes in the Genetic Epidemiology of COPD and Pittsburgh Lung Screening Study Cohorts.

MLA

Choi, Bina, et al. “Quantitative Interstitial Abnormality Progression and Outcomes in the Genetic Epidemiology of COPD and Pittsburgh Lung Screening Study Cohorts.” Chest, vol. 163, no. 1, Jan. 2023, pp. 164–75. EBSCOhost, https://doi.org/10.1016/j.chest.2022.06.030.

APA

Choi, B., Adan, N., Doyle, T. J., San José Estépar, R., Harmouche, R., Humphries, S. M., Moll, M., Cho, M. H., Putman, R. K., Hunninghake, G. M., Kalhan, R., Liu, G. Y., Diaz, A. A., Mason, S. E., Rahaghi, F. N., Pistenmaa, C. L., Enzer, N., Poynton, C., Sánchez-Ferrero, G. V., … Ash, S. Y. (2023). Quantitative Interstitial Abnormality Progression and Outcomes in the Genetic Epidemiology of COPD and Pittsburgh Lung Screening Study Cohorts. Chest, 163(1), 164–175. https://doi.org/10.1016/j.chest.2022.06.030

Chicago

Choi, Bina, Najma Adan, Tracy J Doyle, Ruben San José Estépar, Rola Harmouche, Stephen M Humphries, Matthew Moll, et al. 2023. “Quantitative Interstitial Abnormality Progression and Outcomes in the Genetic Epidemiology of COPD and Pittsburgh Lung Screening Study Cohorts.” Chest 163 (1): 164–75. doi:10.1016/j.chest.2022.06.030.